Vaxil Bio Ltd. (VXLLF)

Market Cap	412.87K +1.5%
Revenue (ttm)	n/a
Net Income	266.88K
EPS	0.08
Shares Out	n/a
PE Ratio	1.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,040
Open	0.0270
Previous Close	n/a
Day's Range	0.0270 - 0.0270
52-Week Range	0.0061 - 0.5000
Beta	-0.87
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Vaxil Bio

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Gadi Levin
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: VXLLF

Financial Performance

Financial numbers in CAD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 26, 2026

Data Sources Report a data error